Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer science

Showing results (871-880 of 7,117) with videos related to

Pageof 712
Sort By:
Cancer Science|March 21, 2012
Morphophenotypic characteristics of intralymphatic cancer and stromal cells susceptible to lymphogenic metastasisYuki Matsumura, Genichiro Ishii, Keiju Aokage, et al.
Cancer Science|March 28, 2012
Twists in views on RB functions in cellular signaling, metabolism and stem cellsChiaki Takahashi, Nobunari Sasaki, Shunsuke Kitajima
Cancer Science|March 28, 2012
Phase I study of BCX1777 (forodesine) in patients with relapsed or refractory peripheral T/natural killer-cell malignanciesMichinori Ogura, Kunihiro Tsukasaki, Hirokazu Nagai, et al.
Cancer Science|April 21, 2012
Phase I trial of gemcitabine and candesartan combination therapy in normotensive patients with advanced pancreatic cancer: GECA1Yousuke Nakai, Hiroyuki Isayama, Hideaki Ijichi, et al.
Cancer Science|April 19, 2012
Overexpression of DNA polymerase iota (Polι) in esophageal squamous cell carcinomaJundong Zhou, Shuyu Zhang, Ling Xie, et al.
Cancer Science|April 11, 2012
Sorting nexin 5 of a new diagnostic marker of papillary thyroid carcinoma regulates Caspase-2Shihoko Ara, Tomoki Kikuchi, Hiroshi Matsumiya, et al.
Cancer Science|February 17, 2012
Phase I study of anti-CD22 immunoconjugate inotuzumab ozogamicin plus rituximab in relapsed/refractory B-cell non-Hodgkin lymphomaMichinori Ogura, Kiyohiko Hatake, Kiyoshi Ando, et al.
Cancer Science|December 8, 2011
Aberrant DNA methylation profile in pleural fluid for differential diagnosis of malignant pleural mesotheliomaMasanori Fujii, Nobukazu Fujimoto, Akio Hiraki, et al.
Cancer Science|March 13, 2012
Low expression of RECK indicates a shorter survival for patients with invasive breast cancerYue Zhang, Shaoqiang Cheng, Guoqiang Zhang, et al.
Cancer Science|March 13, 2012
Radiosensitization effect of poly(ADP-ribose) polymerase inhibition in cells exposed to low and high liner energy transfer radiationTakahisa Hirai, Hidenori Shirai, Hiroaki Fujimori, et al.
Pageof 712

Showing results (871-880 of 7,117) with videos related to

Sort By:
Pageof 712
Cancer Science|March 21, 2012
Morphophenotypic characteristics of intralymphatic cancer and stromal cells susceptible to lymphogenic metastasisYuki Matsumura, Genichiro Ishii, Keiju Aokage, et al.
Cancer Science|March 28, 2012
Twists in views on RB functions in cellular signaling, metabolism and stem cellsChiaki Takahashi, Nobunari Sasaki, Shunsuke Kitajima
Cancer Science|March 28, 2012
Phase I study of BCX1777 (forodesine) in patients with relapsed or refractory peripheral T/natural killer-cell malignanciesMichinori Ogura, Kunihiro Tsukasaki, Hirokazu Nagai, et al.
Cancer Science|April 21, 2012
Phase I trial of gemcitabine and candesartan combination therapy in normotensive patients with advanced pancreatic cancer: GECA1Yousuke Nakai, Hiroyuki Isayama, Hideaki Ijichi, et al.
Cancer Science|April 19, 2012
Overexpression of DNA polymerase iota (Polι) in esophageal squamous cell carcinomaJundong Zhou, Shuyu Zhang, Ling Xie, et al.
Cancer Science|April 11, 2012
Sorting nexin 5 of a new diagnostic marker of papillary thyroid carcinoma regulates Caspase-2Shihoko Ara, Tomoki Kikuchi, Hiroshi Matsumiya, et al.
Cancer Science|February 17, 2012
Phase I study of anti-CD22 immunoconjugate inotuzumab ozogamicin plus rituximab in relapsed/refractory B-cell non-Hodgkin lymphomaMichinori Ogura, Kiyohiko Hatake, Kiyoshi Ando, et al.
Cancer Science|December 8, 2011
Aberrant DNA methylation profile in pleural fluid for differential diagnosis of malignant pleural mesotheliomaMasanori Fujii, Nobukazu Fujimoto, Akio Hiraki, et al.
Cancer Science|March 13, 2012
Low expression of RECK indicates a shorter survival for patients with invasive breast cancerYue Zhang, Shaoqiang Cheng, Guoqiang Zhang, et al.
Cancer Science|March 13, 2012
Radiosensitization effect of poly(ADP-ribose) polymerase inhibition in cells exposed to low and high liner energy transfer radiationTakahisa Hirai, Hidenori Shirai, Hiroaki Fujimori, et al.
Pageof 712